MedPro

Informed Consent
The American Medical Association notes that informed consent is more than simply getting a patient to sign a written consent form. It is a process of communication between a patient and physician that results in the patient’s authorization or agreement to undergo a specific medical intervention. For additional guidance on informed consent, please refer to the informed consent recommendations listed below.

iMedConsent™ PE
The iMedConsent™ PE application is a web-based software tool that standardizes and automates the informed consent process. Procedure-specific consent forms are produced from a comprehensive library of informed consent documents that detail the treatments contemplated by individual patients. Accessible from all internet-connected computers within a practice, this resource also includes patient education documents, common forms for use in the practice, information sheets for prescription and over-the-counter medications, and an extensive image gallery. The iMedConsent™ PE application aids with the communication and documentation of all aspects of the shared decision-making process.

Special Offer for MedPro Policyholders
By special arrangement with The Medical Protective Company, the iMedConsent™ PE application is available to MedPro Policyholders at a 30% discount. The discount will apply both to new orders and to annual subscription renewal rates. Discounts to be computed automatically at the time of purchase.
• List Price: $695.00 (Year 1 – single physician) MedPro Policyholder Price: $486.50
• List Price: $295.00 (Annual content renewal) MedPro Policyholder Price: $206.50
Please see the Medical Protective Policyholder Price List for complete details.

Getting Started

If you would like to trial the iMedConsent™ PE application, click here. You can be up and running in 60 seconds.
     ○ View sample consent documents in the Consents – Samples folder.
     ○ Explore the consent forms and other documents available to your practice
         in the applicable folder for your surgical or medical specialty.
A free 30-day evaluation of the iMedConsent™ PE application is available to MedPro Policyholders - after creating your login credentials by clicking here, simply notify our Customer Service Team at 1-800-482-7963 or at enterprise@dialogmedical.com to begin your free 30-day evaluation.
Already a registered user of the web-based iMedConsent™ PE application? If yes, click here to log in.
To purchase, please contact our Customer Service Team at 1-800-482-7963.

Informed Consent Recommendations

Informed consent is more than a signature on a form; it is a process that defines the expectations and responsibilities of the physician and patient.
The informed consent process should occur well in advance of the treatment or procedure – preferably in the physician’s office and not in the pre-operative holding area.
The informed consent process should include a thorough discussion of all significant risks (including death), anticipated benefits, and alternatives to treatment, explained in language the patient can understand.
Anesthesia risks should be addressed as separate issues, with the specific risks, anticipated benefits and alternatives explained.
The patient has a right to refuse any or all parts of the proposed treatment or procedure.
The informed consent process should always be recorded as a note in the patient record, in addition to inclusion of the signed consent form. That note should include an assessment of the patient’s understanding.
While the physician’s staff may assist with aspects of patient education, the actual achievement of consent to treatment is the physician’s non-delegable duty.
Written materials, models, pictures and videos may be used to facilitate the informed consent process.
The patient should receive a copy of any informed consent forms after she/he signs them.
Ensure the patient is competent to provide meaningful consent to treatment, including being adequately “health literate.” If the patient is not competent, the patient’s legal surrogate must provide consent. The relationship of the surrogate to the patient should be noted on both the consent form and in the note.
If a translator assists with the informed consent process, his or her name and role should be documented on both the consent form and in the note.